[Clinical aspects and therapy of mycosis fungoides].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009779:Occlusive Dressings; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011855:Radiodermatitis; D011879:Radiotherapy Dosage; D012878:Skin Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014467:Ultraviolet Therapy
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D011241:Prednisone; D008727:Methotrexate
Zur Klinik und Therapie der Mycosis fungoides.